Whipple's disease
(Redirected from Intestinal lipodystrophy)
Whipple's disease, also known as intestinal lipodystrophy, is a rare infectious disease caused by the bacterium Tropheryma whipplei. This condition primarily affects the small intestine but can also involve other parts of the body such as the heart, brain, and joints. Whipple's disease was first described by Dr. George Hoyt Whipple in 1907 and is characterized by malabsorption, weight loss, joint pain, and other systemic symptoms.
Symptoms[edit | edit source]
The symptoms of Whipple's disease can vary widely depending on which organs are affected. Common symptoms include chronic diarrhea, abdominal pain, weight loss, joint pain, fever, and fatigue. Some individuals may also experience neurological symptoms such as confusion, memory loss, and vision problems.
Causes[edit | edit source]
Whipple's disease is caused by infection with the bacterium Tropheryma whipplei. It is believed that the bacterium is acquired through oral ingestion, although the exact mode of transmission is not well understood. Individuals with weakened immune systems are at higher risk of developing Whipple's disease.
Diagnosis[edit | edit source]
Diagnosing Whipple's disease can be challenging due to its nonspecific symptoms. A combination of clinical evaluation, imaging studies, blood tests, and biopsy of affected tissues is usually necessary to confirm the diagnosis. The gold standard for diagnosis is the identification of Tropheryma whipplei in biopsy samples using special staining techniques.
Treatment[edit | edit source]
The primary treatment for Whipple's disease is long-term antibiotic therapy. A combination of antibiotics such as ceftriaxone, doxycycline, and hydroxychloroquine is typically used to eradicate the bacterium. In some cases, surgery may be necessary to remove infected tissue or repair damage caused by the disease.
Prognosis[edit | edit source]
With early diagnosis and appropriate treatment, the prognosis for Whipple's disease is generally good. However, if left untreated, the disease can be fatal. Regular follow-up with healthcare providers is important to monitor for any signs of disease recurrence or complications.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen